In the same context, other physiological changes may explain insulin resistance in obese subjects, such as the increase of fatty acid synthase (FAS) and choline/ethanolamine phosphotransferase 1 (CEPT1) enzymes activity, and/or expression. The gene discussed is CEPT1; the disease is Insulin resistance.